Kai Lei

579 total citations
23 papers, 347 citations indexed

About

Kai Lei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kai Lei has authored 23 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kai Lei's work include Cancer-related molecular mechanisms research (4 papers), Synthesis and biological activity (3 papers) and MicroRNA in disease regulation (3 papers). Kai Lei is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Synthesis and biological activity (3 papers) and MicroRNA in disease regulation (3 papers). Kai Lei collaborates with scholars based in China, United States and Germany. Kai Lei's co-authors include Lijuan Chen, Mingli Xiang, Liang Ma, Xiaolin Liang, Zhuang Yang, Aihua Peng, Jinying Chen, Guangcheng Wang, Dong Cao and Huayue Lin and has published in prestigious journals such as Nature Communications, Cancer Cell and Journal of Dental Research.

In The Last Decade

Kai Lei

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Lei China 10 145 134 77 61 61 23 347
Pierre Champelovier France 12 165 1.1× 102 0.8× 65 0.8× 34 0.6× 40 0.7× 17 354
Srinivas Chatla United States 10 217 1.5× 184 1.4× 69 0.9× 27 0.4× 69 1.1× 19 409
Han-Li Huang Taiwan 12 277 1.9× 102 0.8× 98 1.3× 30 0.5× 42 0.7× 18 387
Hanumantharayappa Bharathkumar India 9 209 1.4× 150 1.1× 121 1.6× 19 0.3× 55 0.9× 14 374
Eun Jae Park South Korea 14 160 1.1× 134 1.0× 112 1.5× 102 1.7× 21 0.3× 25 338
Hideaki Suna Japan 9 93 0.6× 92 0.7× 143 1.9× 114 1.9× 39 0.6× 11 384
Nicholas Regan United States 7 196 1.4× 57 0.4× 135 1.8× 28 0.5× 34 0.6× 7 334
Petra E. van der Wouden Netherlands 12 340 2.3× 89 0.7× 116 1.5× 93 1.5× 19 0.3× 21 517
Pengxing He China 11 328 2.3× 47 0.4× 109 1.4× 53 0.9× 55 0.9× 21 444

Countries citing papers authored by Kai Lei

Since Specialization
Citations

This map shows the geographic impact of Kai Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lei more than expected).

Fields of papers citing papers by Kai Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lei. The network helps show where Kai Lei may publish in the future.

Co-authorship network of co-authors of Kai Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Lei. A scholar is included among the top collaborators of Kai Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Lei. Kai Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Luming, Ziwei Xiang, Kai Lei, & Xu-Yao Zhang. (2025). Multi-Task Model Fusion via Adaptive Merging. 1–5.
2.
Lei, Kai, et al.. (2025). Integrative multi-omics and Mendelian randomization analysis reveal SPP1+ tumor-associated macrophage-driven prognostic signature for hepatocellular carcinoma. Frontiers in Molecular Biosciences. 12. 1594610–1594610. 3 indexed citations
3.
Lei, Kai, Jing Huang, Kefeng Wang, et al.. (2025). Single-cell analysis reveals transcriptomic features and therapeutic targets in primary pulmonary lymphoepithelioma-like carcinoma. Communications Biology. 8(1). 394–394.
4.
Lei, Kai, Nan Lü, Jing Huang, et al.. (2024). CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1. Journal of Experimental & Clinical Cancer Research. 43(1). 124–124. 16 indexed citations
5.
Lei, Kai, Ke Xu, Jing Huang, et al.. (2024). The FGF6 amplification mutation plays an important role in the progression and treatment of malignant meningioma. Translational Oncology. 45. 101974–101974. 1 indexed citations
6.
7.
Zhang, Yifan, Guangjian Liu, Qianwen Zeng, et al.. (2024). CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 42(8). 1370–1385.e9. 51 indexed citations
8.
Lei, Kai, et al.. (2023). A novel protein encoded by circUBE4B promotes progression of esophageal squamous cell carcinoma by augmenting MAPK/ERK signaling. Cell Death and Disease. 14(6). 346–346. 11 indexed citations
9.
He, Xinyu, Fan Xiao, Lei Qu, et al.. (2023). LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. Nature Communications. 14(1). 2253–2253. 34 indexed citations
10.
Lei, Kai, Lin Li, Kexi Wang, et al.. (2023). Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2023. 1–31. 7 indexed citations
11.
12.
Lei, Kai, Duoguang Wu, Kefeng Wang, et al.. (2022). hsa_circ_0001741 promotes esophageal squamous cell carcinoma stemness, invasion and migration by sponging miR-491-5p to upregulate NOTCH3 expression.. PubMed. 12(5). 2012–2031. 7 indexed citations
13.
Lei, Kai, Kexi Wang, Wenjian Wang, et al.. (2022). Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.. PubMed. 12(11). 5160–5182. 9 indexed citations
14.
Qian, Yanyan, et al.. (2022). Prognostic Value of Pd-L1 Expression Combined with Hypoxia-Associated Immunosuppression in Hepatocellular Carcinoma. Biomarkers in Medicine. 16(6). 435–448. 1 indexed citations
15.
Ran, Yan, Heying Pei, Caifeng Xie, et al.. (2015). Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice. Molecular Diversity. 19(2). 333–346. 5 indexed citations
16.
Wang, Guangcheng, Chunyan Li, Lin He, et al.. (2014). Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorganic & Medicinal Chemistry. 22(7). 2060–2079. 100 indexed citations
17.
Shao, Mingfeng, Yiming Yuan, Kai Lei, et al.. (2014). Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach. Molecular Diversity. 18(2). 335–344. 8 indexed citations
18.
Xiang, Mingli, Kai Lei, Yu‐Chun Lin, et al.. (2013). In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features. Drug Design Development and Therapy. 7. 789–789. 13 indexed citations
19.
Cao, Dong, Xiaolei Han, Guangcheng Wang, et al.. (2013). Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents. European Journal of Medicinal Chemistry. 62. 579–589. 37 indexed citations
20.
Lei, Kai. (2004). The effects of breviscapine on platelet aggregation and intra-platelet free calcium. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Champelovier Breakdown of academic impact, for papers by Srinivas Chatla Breakdown of academic impact, for papers by Han-Li Huang Breakdown of academic impact, for papers by Hanumantharayappa Bharathkumar Breakdown of academic impact, for papers by Eun Jae Park Breakdown of academic impact, for papers by Hideaki Suna Breakdown of academic impact, for papers by Nicholas Regan Breakdown of academic impact, for papers by Petra E. van der Wouden Breakdown of academic impact, for papers by Pengxing He
Rankless by CCL
2026